Neurogastrx
OverviewSuggest Edit
Neurogastrx is a biopharmaceutical company developing products for the treatment gastrointestinal disorders treatment. Its lead product is under development for the treatment of gastroparesis, a debilitating condition caused by abnormal gastric function.
| Type | Private | |
| Founded | 2012 | |
| HQ | Woburn, MA, US | Map |
| Website | neurogastrx.com |
Latest Updates
| Employees (est.) (Oct 2021) | 11 | (+10%) |
| Cybersecurity rating | A | More |
Key People/Management at Neurogastrx
Klaus Veitinger
Jim O'Mara
David Allison
Sara Burke
Kevin Koch
Brenda Jeglinski
Neurogastrx Office Locations
Neurogastrx Financials and Metrics
Summary Metrics
Founding Date | 2012 |
Neurogastrx total Funding | $45 m |
Neurogastrx latest funding size | $45 m |
Time since last funding | 4 years ago |
Neurogastrx investors | 5AM Ventures, OrbiMed, venBio Partners |
Neurogastrx Cybersecurity Score
Neurogastrx Online and Social Media Presence
Neurogastrx's Trends
Neurogastrx Blogs
Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders
Neurogastrx Frequently Asked Questions
When was Neurogastrx founded?
Neurogastrx was founded in 2012.
Who are Neurogastrx key executives?
Neurogastrx's key executives are Klaus Veitinger, Jim O'Mara and David Allison.
How many employees does Neurogastrx have?
Neurogastrx has 11 employees.
Who are Neurogastrx competitors?
Competitors of Neurogastrx include Alexion Pharmaceuticals, KiOmed Pharma and CorMedix.
Where is Neurogastrx headquarters?
Neurogastrx headquarters is located at 60 Unicorn Park Dr, Woburn.
Where are Neurogastrx offices?
Neurogastrx has an office in Woburn.
How many offices does Neurogastrx have?
Neurogastrx has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies